Carbohydrate Mimetic Peptides Augment Carbohydrate-Reactive Immune Responses in the Absence of Immune Pathology

Among the most challenging of clinical targets for cancer immunotherapy are Tumor Associated Carbohydrate Antigens (TACAs). To augment immune responses to TACA we are developing carbohydrate mimetic peptides (CMPs) that are sufficiently potent to activate broad-spectrum anti-tumor reactivity. Howeve...

Descripción completa

Detalles Bibliográficos
Autores principales: Hennings, Leah, Artaud, Cecile, Jousheghany, Fariba, Monzavi-Karbassi, Behjatolah, Pashov, Anastas, Kieber-Emmons, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Molecular Diversity Preservation International (MDPI) 2011
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3763416/
https://www.ncbi.nlm.nih.gov/pubmed/24213131
http://dx.doi.org/10.3390/cancers3044151

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3763416/
https://www.ncbi.nlm.nih.gov/pubmed/24213131
http://dx.doi.org/10.3390/cancers3044151

Ejemplares similares